TORONTO – TheNewswire – December 5, 2019 – TruTrace Technologies Inc. (CNSX:TTT.CN) (OTC:TTTSF) (“TruTrace” or the “Company“), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that CEO Robert Galarza will speak at the CBD Expo WEST conference to be held in San Diego, California on December 5-6, 2019.
Mr. Galarza will speak on a panel on Thursday, December 5 titled “IP Freely: Protecting Your Intellectual Property.” The panelists will discuss effective methods for safeguarding intellectual property, in addition to examining why this is such a worthwhile endeavor. In the rapidly-expanding CBD marketplace, it is more important than ever to ensure that valuable ideas are not vulnerable to those looking to take advantage.
“This event is a great opportunity to exchange ideas with manufacturers and other stakeholders participating in the fast-growing CBD space,” said TruTrace Technologies CEO Robert Galarza. “Our StrainSecure traceability platform certainly has benefits for consumers and medical professionals, but equally important is its ability to catalog and protect the intellectual property of the companies developing and selling the products.”
CBD Expo WEST is the finale for the CBD Expo Tour, a series of events designed to bring together formulators across the natural products industry and unite them with the comprehensive knowledge and resources they need to adapt and thrive in the ever-growing cannabinoid realm. The event features more than 75 exhibitors, along with a substantial lineup of speaker presentations, panel discussions, demos and workshops from experts in the research, technology, production, globalization and sale of CBD products. More information is available on the CBD Expo website.
About TruTrace Technologies:
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.
For More Information:
Robert Galarza, Chief Executive Officer and Director, 844-656-3629. Investor Inquiries: Swapan Kakumanu, Chief Financial Officer, 844-656-3629, email@example.com
Disclaimer for Forward-Looking Information
This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of TruTrace, including statements regarding: the ability of TruTrace Technologies’ platform to benefit consumers and medical professionals and to catalog and protect intellectual property, and the rapid growth of the CDB marketplace. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that it will prove to be correct and actual results and future events could differ materially from those anticipated in such information. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with: general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States, and elsewhere; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; and other risks beyond the Company’s control. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company. Readers are cautioned not to place undue reliance on any forward-looking information contained in this news release. Forward-looking information contained in this news release is provided as of the date of this news release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.